Funded Tech Companies
Rezo Therapeutics
Rezo Therapeutics is a biopharmaceutical growth company, based in London England. Investment was provided by SR One Capital Management, Norwest Venture Partners and Liquid 2 Ventures.
Company Overview
Company Name
Rezo Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Cottage Place 320 City Road
London England, EC1V 2NZ
UK
London England, EC1V 2NZ
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Rezo is tackling some of the most difficult challenges in medicine by mapping and therapeutically targeting networks that go awry in disease. Starting with genomic data, Rezo integrates distinct, unbiased technologies coupled with artificial intelligence to identify targets and therapies. Based on pioneering work from the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco, our mission is to break the mold in traditional drug development through the convergence of distinct scientific disciplines and insights from academia and industry. Rezo's proprietary platform is applicable across a broad range of diseases. The initial focus of Rezo is in oncology, with plans to explore additional therapeutic areas through collaborations and partnerships.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/17/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nevan Krogan
Co-Founder
Sourav Bandyopadhyay
Co-Founder
Natalia Jura
Co-Founder
George Scangos
Co-Founder
Kevan Shokat
Company Investors
- SR One Capital Management
- Norwest Venture Partners
- Liquid 2 Ventures
- Andreessen Horowitz
- SV Angel
- Hawktail Management
- UCSF Foundation Investment Company
Browse more funded tech companies:
Share this article
About Our VC Funding Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs